Brooktree Capital Management’s Cardlytics CDLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $399K | Buy |
242,249
+18,624
| +8% | +$30.6K | 0.26% | 29 |
|
|
2025
Q1 | $407K | Buy |
223,625
+48,415
| +28% | +$88.1K | 0.31% | 22 |
|
|
2024
Q4 | $650K | Buy |
175,210
+7,568
| +5% | +$28.1K | 0.48% | 21 |
|
|
2024
Q3 | $536K | Buy |
167,642
+33,169
| +25% | +$106K | 0.44% | 23 |
|
|
2024
Q2 | $1.1M | Sell |
134,473
-4,497
| -3% | -$36.9K | 0.94% | 21 |
|
|
2024
Q1 | $2.01M | Buy |
138,970
+21,150
| +18% | +$306K | 1.55% | 18 |
|
|
2023
Q4 | $1.09M | Sell |
117,820
-1,422
| -1% | -$13.1K | 0.88% | 22 |
|
|
2023
Q3 | $1.97M | Sell |
119,242
-1,216
| -1% | -$20.1K | 1.64% | 19 |
|
|
2023
Q2 | $761K | Buy |
120,458
+3,594
| +3% | +$22.7K | 0.58% | 23 |
|
|
2023
Q1 | $397K | Buy |
116,864
+75,596
| +183% | +$257K | 0.31% | 27 |
|
|
2022
Q4 | $239K | Sell |
41,268
-55,252
| -57% | -$319K | 0.2% | 31 |
|
|
2022
Q3 | $907K | Buy |
96,520
+62,486
| +184% | +$587K | 0.75% | 25 |
|
|
2022
Q2 | $759K | Buy |
34,034
+15,393
| +83% | +$343K | 0.57% | 30 |
|
|
2022
Q1 | $1.03M | Buy |
+18,641
| New | +$1.03M | 0.67% | 32 |
|